
Loading, please wait...

Loading, please wait...

To improve healthcare accessibility, the Maharashtra state health department will soon expand MPJAY cancer treatment. Consequently, the government will include advanced therapies and diagnostic tools in the Mahatma Jyotiba Phule Jan Arogya Yojana. Specifically, State Health Minister Prakash Abitkar announced this decision during a high-level meeting in Mumbai. Therefore, this policy change will greatly benefit thousands of patients across the state.
Additionally, the health department aims to strengthen the state's clinical infrastructure. Currently, nine cancer day care or ambulatory centres are operational in Maharashtra. However, the health department plans to establish 27 more such centres in the near future. Minister Abitkar emphasized that robust coordination between the public and private sectors is essential. Moreover, this partnership will help the state combat the rising number of cancer cases. For screening purposes, the health department currently runs one diagnostic van in each of the state's eight administrative circles. As a result, healthcare workers have successfully screened over three crore citizens so far.
Furthermore, the state will introduce cutting-edge clinical options under the revised scheme. Patients will soon receive advanced immunotherapy, which enhances the body's natural defenses to destroy cancer cells. In addition, the scheme will cover highly precise diagnostic tools like positron emission tomography (PET) scans. Previously, patients had to bear these high-end diagnostic costs out of their own pockets. Consequently, including these services will significantly ease the financial burden on families. In the meantime, the Maharashtra Cancer Warriors initiative continues to deliver vital oncology services. Expert oncologists voluntarily support this initiative to provide diagnostic and therapeutic help to patients.
During the high-level meeting, representatives from a South Korean institute presented a lecture on liquid biopsy technology. This revolutionary method allows doctors to detect all types of cancer at a very early stage. Thus, adopting such technology could transform oncology screening and diagnosis in India. Ultimately, early detection remains the most effective tool to improve cancer survival rates. Consequently, health authorities are actively reviewing this technology to assess its implementation viability across public clinics.
Q1: What new cancer treatments and diagnostics will MPJAY include?
The state health department is including advanced immunotherapy and PET scans under the Mahatma Jyotiba Phule Jan Arogya Yojana (MPJAY) to provide modern, comprehensive cancer care.
Q2: How many new ambulatory cancer care centres will Maharashtra establish?
The state plans to add 27 new ambulatory cancer day care centres. These will join the nine currently operational centres to expand regional cancer care access.
Q3: What is the purpose of the Maharashtra Cancer Warriors initiative?
The Maharashtra Cancer Warriors initiative provides expert oncological screening, diagnosis, and treatment services to patients, helping tackle the rising burden of cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Maharashtra health department expands MPJAY to include cancer immunotherapy and PET scans, alongside 27 new ambulatory cancer care centres across the state....
4 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today